Package Leaflet: Information for the User
Psotriol 50 micrograms/g + 0.5 mg/g ointment
calcipotriol/betamethasone
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Psotriol 50 micrograms/g + 0.5 mg/g ointment is used on the skin to treat plaque psoriasis (psoriasis vulgaris) in adults. Psoriasis is caused by the skin cells growing too quickly. This leads to redness, scaling, and thickening of the skin.
Psotriol 50 micrograms/g + 0.5 mg/g ointment contains calcipotriol and betamethasone. Calcipotriol helps to normalise the growth of skin cells, and betamethasone acts to reduce inflammation.
Do not use Psotriol 50 micrograms/g + 0.5 mg/g ointment
Since Psotriol 50 micrograms/g + 0.5 mg/g ointment contains a strong steroid, do not use it on skin affected by:
Warnings and precautions
Consult your doctor or pharmacist before starting to use Psotriol 50 micrograms/g + 0.5 mg/g ointment if:
Special precautions
Contact your doctor if you experience blurred vision or other visual disturbances.
Children
Psotriol 50 micrograms/g + 0.5 mg/g ointment is not recommended for use in children under 18 years of age.
Using Psotriol 50 micrograms/g + 0.5 mg/g ointment with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Pregnancy, breastfeeding, and fertility
Do not use Psotriol 50 micrograms/g + 0.5 mg/g ointment if you are pregnant (or think you may be pregnant) or if you are breastfeeding, unless you have agreed this with your doctor. If your doctor agrees that you can breastfeed, be careful and do not apply Psotriol 50 micrograms/g + 0.5 mg/g ointment to the breast area.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
This medicine does not affect your ability to drive or use machines.
Psotriol 50 micrograms/g + 0.5 mg/g ointment contains butylhydroxytoluene (E321)
Butylhydroxytoluene (E321) may cause local skin reactions (such as contact dermatitis) or irritation of the eyes and mucous membranes.
Follow exactly the instructions for administration of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
How to apply Psotriol 50 micrograms/g + 0.5 mg/g ointment: Cutaneous use.
Instructions for proper use:
Duration of treatment
If you are using other medicines that contain calcipotriol, the total amount of medicines containing calcipotriol should not exceed 15 grams per day, and the treated area should not exceed 30% of the total body surface area.
What to expect when using Psotriol 50 micrograms/g + 0.5 mg/g ointment
Most patients see noticeable results after 2 weeks, even if the psoriasis has not completely cleared at that time.
If you use more Psotriol 50 micrograms/g + 0.5 mg/g ointment than you should
Consult your doctor if you have used more than 15 grams in one day. Overuse of Psotriol 50 micrograms/g + 0.5 mg/g ointment can cause a problem with the calcium in your blood, which usually returns to normal when treatment is stopped. Your doctor may need to perform a blood test to check that using too much ointment has not caused a problem with the calcium in your blood. Prolonged and excessive use can also cause your adrenal glands to stop working properly (these are glands near the kidneys that produce hormones).
Contact the Toxicology Information Service, telephone 91 562 04 20, stating the medicine and the amount used.
If you forget to use Psotriol 50 micrograms/g + 0.5 mg/g ointment
Do not apply a double dose to make up for forgotten doses.
If you stop using Psotriol 50 micrograms/g + 0.5 mg/g ointment
Use of Psotriol 50 micrograms/g + 0.5 mg/g ointment should be stopped as indicated by your doctor. It may be necessary to stop using this medicine gradually, especially if you have been using it for a long time.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Tell your doctor/nurse immediately or as soon as possible if you experience any of the following side effects. You may need to stop your treatment.
The following serious side effects have been reported for Psotriol 50 micrograms/g + 0.5 mg/g ointment:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
It is known that some serious side effects are caused by betamethasone (a strong steroid), one of the components of Psotriol 50 micrograms/g + 0.5 mg/g ointment. If you experience any of these serious side effects, tell your doctor as soon as possible. These side effects are more likely to occur after long-term use, when used on skin folds (e.g. groin, armpits, or under the breasts), when covered, or when used on large areas of skin. The side effects include:
Serious side effects caused by calcipotriol
Less serious side effects
The following less serious side effects have been reported for Psotriol 50 micrograms/g + 0.5 mg/g ointment.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Less serious side effects caused by the use of betamethasone, especially during prolonged use, include:
Less serious side effects caused by calcipotriol include:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and tube after EXP. The expiry date is the last day of the month stated.
Do not store above 25°C.
Do not refrigerate.
The tube should be discarded 1 year after the first opening. Write the date of the first opening of the tube on the space provided on the carton.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Psotriol 50 micrograms/g + 0.5 mg/g ointment
The active substances are:
Calcipotriol and betamethasone.
One gram of ointment contains 50 micrograms of calcipotriol (as monohydrate) and 0.5 mg of betamethasone (as dipropionate).
The other ingredients are:
Liquid paraffin, polyoxypropylene stearyl ether, white paraffin (contains all-rac-α-tocopherol), butylhydroxytoluene (E321)
Appearance of the product and pack size
Psotriol 50 micrograms/g + 0.5 mg/g ointment is a white to yellowish ointment, available in aluminum/epoxyphenol tubes with a polyethylene screw cap.
Pack sizes: 15 g, 30 g, 35 g, 50 g, 60 g, 100 g, 100 g (in a pack of 2 x 50 g), 120 g, 120 g (in a pack of 2 x 60 g).
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Mibe Pharma España S.L.U.
Amaltea 9, 4th floor, letter B,
28045, Madrid
Spain
Manufacturer
Mibe GmbH Arzneimittel
Münchener Strasse 15
06796 - Brehna
Germany
Sun-Farm Sp. z. o. o.
Dolna 21
Lomianki, 05-092Mazowieckie
Poland
This medicine is authorised in the Member States of the European Economic Area under the following names:
Austria: Psotriol 50 Mikrogramm/g + 0,5 mg/g Salbe
Belgium: Calcipotriol/betamethason Dermapharm 50 microgram/g + 0,5 mg/g zalf/pommade/Salbe
Germany: Calcipotriderm comp. 50 Mikrogramm/g + 0,5 mg/g Salbe
Spain: Psotriol 50 microgramos/g + 0,5 mg/g pomada
Croatia: Psotriol 50 μg/g + 500 μg/g mast
Italy: Calcipotriol/Betamethasone Dermapharm 50 micrograms/g + 0.5 mg/g ointment
Poland: Psotriol
Date of last revision of this leaflet: May 2019
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of PSOTRIOL 50 micrograms/g + 0.5 mg/g OINTMENT in October, 2025 is around 44.69 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.